To that end, we isolated CD14+ TAMs from single-cell suspensions of primary human LUSC tumors, treated them with E-301 LOF or E-301, and cocultured them with autologous CD8 tumor-infiltrating lymphocytes (TILs; Fig. 5F). The gene discussed is CD8A; the disease is neoplasm.